Childress Capital Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $680K | Buy |
6,327
+264
| +4% | +$28.4K | 0.17% | 91 |
|
|
2025
Q1 | $612K | Sell |
6,063
-138
| -2% | -$13.9K | 0.18% | 83 |
|
|
2024
Q4 | $554K | Buy |
6,201
+350
| +6% | +$31.3K | 0.15% | 89 |
|
|
2024
Q3 | $490K | Buy |
5,851
+106
| +2% | +$8.88K | 0.13% | 114 |
|
|
2024
Q2 | $442K | Sell |
5,745
-164
| -3% | -$12.6K | 0.12% | 114 |
|
|
2024
Q1 | $405K | Sell |
5,909
-764
| -11% | -$52.3K | 0.12% | 112 |
|
|
2023
Q4 | $386K | Buy |
6,673
+169
| +3% | +$9.77K | 0.12% | 111 |
|
|
2023
Q3 | $343K | Buy |
+6,504
| New | +$343K | 0.11% | 108 |
|
|
2023
Q1 | – | Sell |
-6,201
| Closed | -$287K | – | 101 |
|
|
2022
Q4 | $287K | Buy |
6,201
+212
| +4% | +$9.81K | 0.1% | 136 |
|
|
2022
Q3 | $236K | Buy |
5,989
+615
| +11% | +$24.2K | 0.09% | 143 |
|
|
2022
Q2 | $200K | Buy |
5,374
+71
| +1% | +$2.64K | 0.08% | 162 |
|
|
2022
Q1 | $234K | Buy |
+5,303
| New | +$234K | 0.08% | 164 |
|
|
2021
Q1 | – | Sell |
-1,358
| Closed | -$49K | – | 273 |
|
|
2020
Q4 | $49K | Buy |
+1,358
| New | +$49K | 0.03% | 225 |
|